Encision Inc Quick Ratio (ECIA) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Encision Inc   (ECIA)

Encision Inc 's Quick Ratio

ECIA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Encision Inc 's Cash & cash equivalent grew by 49.7 % in the Q2 2025 sequentially, while Current Liabilities decreased, this led to improvement in Encision Inc 's Quick Ratio to 0.07, Quick Ratio remained below Encision Inc average.

Within Medical Equipment & Supplies industry 152 other companies have achieved higher Quick Ratio than Encision Inc in second quarter 2025. While Quick Ratio total ranking has improved so far during the Q2 2025 to 2732, from total ranking in the first quarter 2025 at 3151.

Explain Quick Ratio?
How much Cash & cash equivalents ECIA´s has?
What are ECIA´s Current Liabilities?




ECIA Quick Ratio (Sep 30 2025)
Q2
(Jun 30 2025)
Q1
(Mar 31 2025)
Q4
(Dec 31 2024)
Q3
(Sep 30 2024)
Q2
Y / Y Current Liabilities Change -5.99 % 7.51 % 29.17 % 51.84 % -2.07 %
Y / Y Cash & cash equivalent Change -68.81 % -82.28 % 505.6 % 250.59 % -24.83 %
Quick Ratio MRQ 0.07 0.04 0.16 0.22 0.2
ECIA's Total Ranking # 2732 # 3151 # 3034 # 1181 # 2945
Seq. Current Liabilities Change -16.14 % -18.91 % -2.2 % 41.35 % -4.1 %
Seq. Cash & cash equivalent Change 49.7 % -81.39 % -26.01 % 51.26 % -14.95 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 153
Healthcare Sector # 698
Overall Market # 2732


Quick Ratio Statistics
High Average Low
1.33 0.36 0.03
(Dec 31 2013)   (Sep 30 2016)




Financial Statements
Encision Inc 's Current Liabilities $ 1 Millions Visit ECIA's Balance sheet
Encision Inc 's Cash & cash equivalent $ 0 Millions Visit ECIA's Balance sheet
Source of ECIA's Sales Visit ECIA's Sales by Geography


Cumulative Encision Inc 's Quick Ratio

ECIA's Quick Ratio for the trailling 12 Months

ECIA Quick Ratio

(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 20.11 % 20.96 % 20.87 % 15.32 % 5.81 %
Y / Y Cash & cash equivalent TTM Growth 12.89 % 22.99 % 91.23 % 22.93 % -13.83 %
Quick Ratio TTM 0.13 0.16 0.2 0.17 0.14
Total Ranking TTM # 3417 # 2856 # 3315 # 1380 # 2547
Seq. Current Liabilities TTM Growth -1.22 % 1.62 % 6.9 % 11.93 % -0.52 %
Seq. Cash & cash equivalent TTM Growth -17.92 % -20.12 % 24.12 % 38.72 % -10.58 %


On the trailing twelve months basis In spite of the year on year decrease in ECIA's Current Liabilities to $1.07 millions, cumulative Quick Ratio to 0.13 below the ECIA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Encision Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 2856 to 3417.

Explain Quick Ratio?
How much Cash & cash equivalents ECIA´s has?
What are ECIA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 201
Healthcare Sector # 906
Within the Market # 3417


trailing twelve months Quick Ratio Statistics
High Average Low
1.12 0.38 0.04
(Dec 31 2021)   (Mar 31 2017)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Precision Optics Corporation Inc   0.18 $ 1.392  Millions$ 7.617  Millions
Zynex inc   0.18 $ 13.259  Millions$ 74.410  Millions
Bellevue Life Sciences Acquisition Corp  0.17 $ 2.177  Millions$ 12.523  Millions
Bausch and Lomb Corp  0.16 $ 310.000  Millions$ 1,896.000  Millions
National Vision Holdings Inc   0.13 $ 56.030  Millions$ 416.965  Millions
Venus Concept Inc   0.13 $ 4.312  Millions$ 32.975  Millions
Northview Acquisition Corp  0.13 $ 3.009  Millions$ 23.540  Millions
Nakamoto Inc   0.11 $ 24.185  Millions$ 214.460  Millions
The Cooper Companies Inc   0.11 $ 110.600  Millions$ 984.900  Millions
Dynatronics Corporation  0.09 $ 0.762  Millions$ 8.426  Millions
Agape Atp Corporation  0.09 $ 0.134  Millions$ 1.485  Millions
P3 Health Partners Inc   0.09 $ 37.714  Millions$ 423.954  Millions
Streamex Corp   0.09 $ 11.045  Millions$ 125.600  Millions
Qhslab Inc   0.07 $ 0.158  Millions$ 2.346  Millions
Encision Inc   0.07 $ 0.072  Millions$ 1.072  Millions
Becton Dickinson And Company  0.06 $ 785.000  Millions$ 12,445.000  Millions
Euda Health Holdings Limited  0.06 $ 0.345  Millions$ 5.836  Millions
Enovis Corp  0.06 $ 33.617  Millions$ 575.443  Millions
Infusystem Holdings Inc  0.05 $ 0.955  Millions$ 18.718  Millions
Biotricity Inc   0.05 $ 1.181  Millions$ 23.614  Millions
Yunhong Green Cti Ltd   0.05 $ 0.387  Millions$ 8.241  Millions
Henry Schein Inc   0.04 $ 136.000  Millions$ 3,068.000  Millions
Globus Medical Inc   0.04 $ 18.754  Millions$ 465.958  Millions
Dror Ortho-Design, Inc.  0.04 $ 0.068  Millions$ 1.727  Millions
Invo Fertility Inc   0.04 $ 0.356  Millions$ 9.245  Millions
Mountain Crest Acquisition Corp V  0.02 $ 0.041  Millions$ 1.837  Millions
Sigyn Therapeutics Inc   0.02 $ 0.086  Millions$ 3.989  Millions
The Pennant Group Inc   0.02 $ 2.336  Millions$ 109.352  Millions
Vsee Health Inc   0.02 $ 0.473  Millions$ 23.422  Millions
Stimcell Energetics Inc   0.02 $ 0.006  Millions$ 0.335  Millions

Date modified: 2026-09-26T06:52:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.